NCT00393315View on ClinicalTrials.gov

P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2007

Conditions
In-Stent Restenosis
Interventions
DEVICE

paclitaxel coated balloon catheter

Trial Locations (10)

12683

Unfallkrankenhaus Berlin, Berlin

13353

Medizinische Klinik, Kardiologie, Charité - Hochschulmedizin Berlin, Berlin

36199

Center for Cardiovascular Diseases, Cardiologic Clinic, Rotenburg A.d. Fulda

44137

Medizinische Klinik, Kardiologie, St.-Johannes -Hospital, Dortmund

61231

Kerckhoff-Clinic Bad Nauheim, Bad Nauheim

64283

Klinikum Darmstadt, Medizinische Klinik I, Darmstadt

66421

University of Saarland, Internal Medicine III, Homburg/Saar

73730

Städtische Kliniken Esslingen, Klinik für Kardiologie, Angiologie und Pneumologie, Esslingen am Neckar

81925

I. Med. Abteilung, Krankenhaus Bogenhausen, München

93053

University of Regensburg, Regensburg

All Listed Sponsors
collaborator

B. Braun Melsungen AG

INDUSTRY

lead

University Hospital, Saarland

OTHER

NCT00393315 - P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses | Biotech Hunter | Biotech Hunter